icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
June 22-26 2022
Back grey_arrow_rt.gif
 
 
 
Sofosbuvir/Velpatasvir (S/V) for the treatment
of HCV infection among vulnerable inner-city residents:
extending the results of clinical trial

 
 
  EASL 2022 June 22-26 London
 
Brian Conway1,2, David Truong1, Leo Yamamoto1, Rossitta Yung1, Shawn Sharma1. 1Vancouver Infectious Diseases Centre, Vancouver, Canada; 2Simon Fraser University, Burnaby, Canada

0622221

0622222

0622223

0622224

0622225

0622226

0622227

0622228